查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1498775

呼吸道合胞病毒药物市场，按类型、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Respiratory Syncytial Virus Drugs Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年呼吸道合胞病毒药物市场规模为58.902亿美元，2024年至2032年复合年增长率为12.90%。

呼吸道合胞病毒药物市场-市场动态

人们对 RSV 感染和诊断的认识不断提高预计将推动市场需求

由于对 RSV 知识的增加和诊断方法的改进，对 RSV 药物和预防性治疗的需求增加，这导致感染诊断更加频繁和早期。对于小孩和老年人来说，呼吸道疾病大多是由 RSV 引起的。 RSV 感染的高盛行率和復发性推动了对有效治疗和预防策略的需求。重要的推动因素包括新型抗病毒药物、单株抗体和疫苗的开发和许可。由于有效治疗方法的引入和治疗替代方案的创新，预计该市场将会成长。

人口老化推动了对有效 RSV 药物的需求，他们更容易受到严重 RSV 感染。预计随着世界人口老化，RSV 发病率将在这群人中攀升，从而推动市场需求。由于生物技术和製药的发展，新疗法和疫苗的开发变得越来越容易。这些技术进步提高了 RSV 药物的可用性和疗效，从而推动了市场扩张。新药和疫苗的监管批准为该行业带来了巨大推动力。 RSV 药物的快速通道指定和有利的监管条件可以促进市场的成长。

呼吸道合胞病毒药物市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 12.90% 左右的复合年增长率成长

根据类型细分，由于美国 FDA 法规的支持，预计已批准的药物细分市场将在 2023 年显示最大的市场份额。

根据应用细分，由于临床试验和治疗中对病毒药物的高需求，临床诊断领域是 2023 年的领先应用。

根据最终用户细分，由于呼吸系统疾病治疗的需求很高，医院细分市场将在 2023 年成为领先的最终用户。

按地区划分，由于拥有先进的医疗基础设施，北美将成为 2023 年的主要收入来源。

呼吸道合胞病毒药物市场-細項分析：

全球呼吸道合胞病毒药物市场根据类型、应用、最终用户和地区进行细分。

市场依类型分为两类：核准药物和适应证外药物。已批准的药物领域主导市场。技术创新以及 FDA 的支持性法规正在促进该细分市场的成长。

根据应用市场分为三类：临床诊断、实验室和其他。线下商店细分市场占据主导地位。合胞病毒感染的日益普及是市场成长的迫切需求。

市场根据最终用户分为三类：医院、诊所和其他。医院领域在市场中占据主导地位，预计在预测期内将保持其高度主导地位。对医疗保健和先进基础设施的大量投资正在加速市场的成长。

呼吸道合胞病毒药物市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。北美正在主导全球市场。由于其大量的研发支出、先进的医疗基础设施和高额的医疗保健支出，该地区占有较大的市场份额，北美是 RSV 药物的最大市场之一。

呼吸道合胞病毒药物市场-竞争格局：

呼吸道合胞病毒药物市场竞争中等。市场上的知名企业专注于製药公司、学术机构和医疗保健提供者之间的合作，这可能会加速 RSV 药物的创造和传播，从而扩大市场。一些主要公司包括阿斯特捷利康 (AstraZeneca)、强生 (Johnson & Johnson)、赛诺菲 (Sanofi)、默克 (Merck & Co.) 以及 Moderna 等新公司。较小的公司正在寻求提供创新的解决方案并获得美国食品和药物管理局的批准。

最近的发展：

2024 年 2 月，葛兰素史克公司 (GSK plc) 获得美国 FDA 批准，扩大其呼吸道合胞病毒疫苗接种范围，涵盖 50 岁以上人口。

2023 年 5 月，辉瑞公司推出了经美国 FDA 批准的二价 RSV 疫苗，用于预防呼吸道疾病。

目录

第一章：呼吸道合胞病毒药物市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的呼吸道合胞病毒药物市场片段
    • 呼吸道合胞病毒药物市场片段（依应用）
    • 最终用户的呼吸道合胞病毒药物市场片段
    • 按国家/地区分類的呼吸道合胞病毒药物市场片段
    • 按地区分類的呼吸道合胞病毒药物市场片段
  • 竞争洞察

第 3 章：呼吸道合胞病毒药物主要市场趋势

  • 呼吸道合胞病毒药物市场驱动因素
    • 市场驱动因素的影响分析
  • 呼吸道合胞病毒药物市场限制
    • 市场限制影响分析
  • 呼吸道合胞病毒药物市场机会
  • 呼吸道合胞病毒药物市场未来趋势

第 4 章：呼吸道合胞病毒药物产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：呼吸道合胞病毒药物市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：呼吸道合胞病毒药物市场格局

  • 2023年呼吸道合胞病毒药物市占分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：呼吸道合胞病毒药物市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 批准的药物
    • 标籤外药物

第 8 章：呼吸道合胞病毒药物市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 临床诊断
    • 实验室
    • 其他的

第 9 章：呼吸道合胞病毒药物市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊所
    • 其他的

第 10 章：呼吸道合胞病毒药物市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美呼吸道合胞病毒药物主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲呼吸道合胞病毒药物主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区呼吸道合胞病毒药物主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲呼吸道合胞病毒药物主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲呼吸道合胞病毒药物主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析-呼吸道合胞病毒药物产业

  • 竞争仪表板
  • 公司简介
    • AbbVie Inc.
    • Swedish Orphan Biovitrum AB
    • AstraZeneca
    • Johnson & Johnson Services Inc.
    • Sanofi
    • Merck & Co., Inc.
    • Bausch Health Companies Inc.
    • Celltrion Inc.
    • mAbxience
    • Enanta Pharmaceuticals, Inc.
    • Moderna, Inc.
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novavax, Inc.
    • Roche Holding AG
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2946

REPORT HIGHLIGHT

Respiratory Syncytial Virus Drugs Market size was valued at USD 5,890.20 Million in 2023, expanding at a CAGR of 12.90% from 2024 to 2032.

A frequent virus that affects the respiratory system is called Respiratory Syncytial Virus (RSV), and it usually affects small children, the elderly, and people with weakened immune systems. Several medications and therapies are used to treat RSV infection.

Respiratory Syncytial Virus Drugs Market- Market Dynamics

Growing awareness about RSV infections and diagnosis is expected to propel market demand

The demand for RSV medications and preventive therapy has increased because of increased knowledge of RSV and improvements in diagnostic methods, which have led to more frequent and earlier infection diagnoses. For both small children and the elderly, respiratory illnesses are mostly caused by RSV. The need for efficient treatments and preventive strategies is driven by the high prevalence and recurrent nature of RSV infections. Important motivators include the creation and licensure of novel antiviral medications, monoclonal antibodies, and vaccinations. The market is expected to grow due to efficient treatments being introduced and treatment alternatives being innovated.

The need for efficient RSV medications is driven by the aging population, who are more vulnerable to severe RSV infections. It is anticipated that as the world's population ages, RSV incidence will climb in this group, driving up market demand. Novel therapies and vaccinations are becoming easier to develop because of developments in biotechnology and pharmaceuticals. The availability and efficacy of RSV medications are improved by these technological advancements, which propels market expansion. Regulatory approvals for novel medications and vaccines provide the industry a big boost. Fast-track designations and favorable regulatory conditions for RSV medicines can contribute to the growth of the market.

Respiratory Syncytial Virus Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.90% over the forecast period (2024-2032)

Based on Type segmentation, the approved drugs segment was predicted to show maximum market share in the year 2023, owing to supportive USFDA regulations.

Based on Application segmentation, the clinical diagnostics segment was the leading Application in 2023, due to the high demand for viral drugs in clinical trials & treatment.

Based on End User segmentation, the hospital segment was the leading End User in 2023, owing to high demand for the treatment of respiratory disorders.

On the basis of region, North America was the leading revenue generator in 2023, owing to presence of advanced healthcare infrastructure.

Respiratory Syncytial Virus Drugs Market- Segmentation Analysis:

The Global Respiratory Syncytial Virus Drugs Market is segmented on the basis of Type, Application, End User, and Region.

The market is divided into two categories based on Type: approved drugs and off-label drugs. The approved drugs segment dominates the market. Technological innovation along with supportive FDA regulations is enhancing the segment growth.

The market is divided into three categories based on the Application: clinical diagnostics, laboratories, and others. The offline stores segment dominates the market. The growing prevalence of syncytial viral infections is a compelling demand for market growth.

The market is divided into three categories based on End Users: hospitals, clinics, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. Significant investment in healthcare and advanced infrastructure is accelerating the growth of the market.

Respiratory Syncytial Virus Drugs Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is dominating the global market. The region holds a larger market share because of its substantial R&D expenditures, sophisticated medical infrastructure, and high healthcare spending, North America is one of the biggest markets for RSV medications.

Respiratory Syncytial Virus Drugs Market- Competitive Landscape:

The respiratory syncytial virus drugs market is moderately competitive. Prominent players in the market focus on partnerships among pharmaceutical firms, academic institutions, and healthcare providers might expedite the creation and dissemination of RSV medications, thereby augmenting the market. Some of the major companies include AstraZeneca, Johnson & Johnson, Sanofi, Merck & Co., and newer companies like Moderna. Smaller companies are looking to offer innovative solutions and get USFDA approvals.

Recent Developments:

In February 2024, GSK plc received the USFDA approvals to expand their respiratory syncytial virus vaccination for people over 50.

In May 2023, Pfizer, Inc. introduced a bivalent RSV vaccine with USFDA approval for preventing respiratory tract illness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DRUGS MARKET KEY PLAYERS

  • AbbVie Inc.
  • Swedish Orphan Biovitrum AB
  • AstraZeneca
  • Johnson & Johnson Services Inc.
  • Sanofi
  • Merck & Co., Inc.
  • Bausch Health Companies Inc.
  • Celltrion Inc.
  • mAbxience
  • Enanta Pharmaceuticals, Inc.
  • Moderna, Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novavax, Inc.
  • Roche Holding AG
  • Others

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Approved drugs
  • Off-label drugs

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DRUGS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Clinical diagnostics
  • Laboratories
  • Others

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DRUGS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinics
  • Others

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Respiratory Syncytial Virus Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Respiratory Syncytial Virus Drugs Market Snippet by Type
    • 2.1.2. Respiratory Syncytial Virus Drugs Market Snippet by Application
    • 2.1.3. Respiratory Syncytial Virus Drugs Market Snippet by End User
    • 2.1.4. Respiratory Syncytial Virus Drugs Market Snippet by Country
    • 2.1.5. Respiratory Syncytial Virus Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Respiratory Syncytial Virus Drugs Key Market Trends

  • 3.1. Respiratory Syncytial Virus Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Respiratory Syncytial Virus Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Respiratory Syncytial Virus Drugs Market Opportunities
  • 3.4. Respiratory Syncytial Virus Drugs Market Future Trends

4. Respiratory Syncytial Virus Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Respiratory Syncytial Virus Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Respiratory Syncytial Virus Drugs Market Landscape

  • 6.1. Respiratory Syncytial Virus Drugs Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Respiratory Syncytial Virus Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Approved drugs
    • 7.1.3. Off-label drugs

8. Respiratory Syncytial Virus Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Clinical diagnostics
    • 8.1.3. Laboratories
    • 8.1.4. Others

9. Respiratory Syncytial Virus Drugs Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Respiratory Syncytial Virus Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Respiratory Syncytial Virus Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Respiratory Syncytial Virus Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Respiratory Syncytial Virus Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Respiratory Syncytial Virus Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Respiratory Syncytial Virus Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Respiratory Syncytial Virus Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AbbVie Inc.
    • 11.2.2. Swedish Orphan Biovitrum AB
    • 11.2.3. AstraZeneca
    • 11.2.4. Johnson & Johnson Services Inc.
    • 11.2.5. Sanofi
    • 11.2.6. Merck & Co., Inc.
    • 11.2.7. Bausch Health Companies Inc.
    • 11.2.8. Celltrion Inc.
    • 11.2.9. mAbxience
    • 11.2.10. Enanta Pharmaceuticals, Inc.
    • 11.2.11. Moderna, Inc.
    • 11.2.12. Pfizer Inc.
    • 11.2.13. GlaxoSmithKline plc
    • 11.2.14. Novavax, Inc.
    • 11.2.15. Roche Holding AG
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Respiratory Syncytial Virus Drugs Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Respiratory Syncytial Virus Drugs Market, by Type 2019-2032 (USD Million)
  • TABLE Respiratory Syncytial Virus Drugs Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Respiratory Syncytial Virus Drugs Market, by Application 2019-2032 (USD Million)
  • TABLE Respiratory Syncytial Virus Drugs Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Respiratory Syncytial Virus Drugs Market, by End User 2019-2032 (USD Million)
  • TABLE Respiratory Syncytial Virus Drugs Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Respiratory Syncytial Virus Drugs Market, by Region 2019-2032 (USD Million)
  • TABLE North America Respiratory Syncytial Virus Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Respiratory Syncytial Virus Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Respiratory Syncytial Virus Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Respiratory Syncytial Virus Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Respiratory Syncytial Virus Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Respiratory Syncytial Virus Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Respiratory Syncytial Virus Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Respiratory Syncytial Virus Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Respiratory Syncytial Virus Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Respiratory Syncytial Virus Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Respiratory Syncytial Virus Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Respiratory Syncytial Virus Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Respiratory Syncytial Virus Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Respiratory Syncytial Virus Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Respiratory Syncytial Virus Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Respiratory Syncytial Virus Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Respiratory Syncytial Virus Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Respiratory Syncytial Virus Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Respiratory Syncytial Virus Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Respiratory Syncytial Virus Drugs Market, by End User, 2019-2032 (USD Million)